An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 1, 2008, Pages

  Singh, Kumud K ^a   Lieser, Alexis ^b   Ruan, Ping K ^c   Fenton, Terry ^c   Spector, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

Author keywords

central nervous system impairment; children; HIV 1 disease; Mannose binding lectin 2; polymorphisms

Indexed keywords

DIDANOSINE; LAMIVUDINE; MANNOSE BINDING LECTIN 2; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMPLEMENT ACTIVATION; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; MONOTHERAPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION;

EID: 46049088698     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.05.025     Document Type: Article

References (29)

1. Garred P., Larsen F., Madsen H.O., and Koch C. MBL deficiency-revisited. Mol Immunol 40 (2003) 73-84
2. Turner M.W. Mannose-binding lectin (MBL) in health and disease. Immunobiology 199 (1998) 327-339
3. Kilpatrick D.C. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 1572 (2002) 401-413
4. Dommett R.M., Klein N., and Turner M.W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68 (2006) 193-209
5. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386 (1997) 506-510
6. Super M., Thiel S., Lu J., Levinsky R.J., and Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 334 (1989) 1236-1239
7. Valdimarsson H., Stefansson M., Vikingsdottir T., Arason G.J., Koch C., Thiel S., et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 48 (1998) 116-123
8. Koch A., Melbye M., Sorensen P., Homoe P., Madsen H.O., Molbak K., et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285 (2001) 1316-1321
9. Kakkanaiah V.N., Shen G.Q., Ojo-Amaize E.A., and Peter J.B. Association of Low Concentrations of Serum Mannose-Binding Protein with Recurrent Infections in Adults. Clin Diagn Lab Immunol 5 (1998) 319-321
10. Fidler K.J., Wilson P., Davies J.C., Turner M.W., Peters M.J., and Klein N.J. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 30 (2004) 1438-1445
11. Eisen D.P., and Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37 (2003) 1496-1505
12. Boniotto M., Crovella S., Pirulli D., Scarlatti G., Spano A., Vatta L., et al. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 1 (2000) 346-348
13. Faber J., Schuessler T., Finn A., Murdoch C., Zenz W., Habermehl P., et al. Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr Infect Dis J 26 (2007) 243-246
14. Englund J.A., Baker C.J., Raskino C., McKinney R.E., Petrie B., Fowler M.G., et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med 336 (1997) 1704-1712
15. McKinney Jr. R.E., Johnson G.M., Stanley K., Yong F.H., Keller A., O'Donnell K.J., et al. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr 133 (1998) 500-508
16. Singh K.K., Barroga C.F., Hughes M.D., Chen J., Raskino C., McKinney R.E., et al. Genetic influence of CCR5, CCR2 and SDF-1 variants on human immunodeficiency virus (HIV-1) related disease progression and neurological impairment in children with symptomatic HIV-1 infection. J Infect Dis 188 (2003) 1461-1472
17. Steffensen R., Hoffmann K., and Varming K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods 278 (2003) 191-199
18. Boldt A.B., and Petzl-Erler M.L. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 19 (2002) 296-306
19. Boldt A.B., Culpi L., Tsuneto L.T., de Souza I.R., Kun J.F., and Petzl-Erler M.L. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol 67 (2006) 722-734
20. Garred P., Madsen H.O., Balslev U., Hofmann B., Pedersen C., Gerstoft J., et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349 (1997) 236-240
21. Dzwonek A., Novelli V., Bajaj-Elliott M., Turner M., Clapson M., and Klein N. Mannose-binding lectin in susceptibility and progression of HIV-1 infection in children. Antivir Ther 11 (2006) 499-505
22. Turner M.W., and Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2 (2000) 305-322
23. Ji X., Gewurz H., and Spear G.T. Mannose binding lectin (MBL) and HIV. Mol Immunol 42 (2005) 145-152
24. Spear G.T., Zariffard M.R., Xin J., and Saifuddin M. Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin. Immunology 110 (2003) 80-85
25. Heggelund L., Mollnes T.E., Ueland T., Christophersen B., Aukrust P., and Froland S.S. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 32 (2003) 354-361
26. Bax W.A., Cluysenaer O.J., Bartelink A.K., Aerts P.C., Ezekowitz R.A., and van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet 354 (1999) 1094-1095
27. Hibberd M.L., Sumiya M., Summerfield J.A., Booy R., and Levin M. Association of variants of the gene for mannose binding lectin with susceptibility to meningococcal disease. Lancet 353 (1999) 1049-1053
28. Lanzrein A.S., Jobst K.A., Thiel S., Jensenius J.C., Sim R.B., Perry V.H., et al. Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease. Clin Neurosci 9 (1998) 1491-1495
29. Verdu P., Barreiro L.B., Patin E., Gessain A., Cassar O., Kidd J.R., et al. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet 15 (2006) 2650-2658